Advertisement
Review Article| Volume 50, ISSUE 1, P109-119, March 2023

Antenatal Steroids and Tocolytics in Pregnancy

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Committee on Obstetric Practice
        Committee Opinion No. 713: Antenatal corticosteroid therapy for fetal maturation.
        Obstet Gynecol. 2017; 130: e102-e109
        • Carlo W.A.
        • McDonald S.A.
        • Fanaroff A.A.
        • et al.
        Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.
        JAMA. 2011; 306: 2348-2358
      1. Management of preterm labor. Practice Bulletin No. 171. American College of Obstetricians and Gynecologists.
        Obstet Gynecol. 2016; 128: e155-e164
        • Roberts D.
        • Dalziel S.R.
        Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2006; 3: CD004454
        • Bonanno C.
        • Wapner R.J.
        Antenatal corticosteroid treatment: what's happened since Drs Liggins and Howie?.
        Am J Obstet Gynecol. 2009; 200: 448-457
        • Copel J.
        • Silver R.
        Creasy and Resnik's maternal-fetal medicine: principles and practice E-book.
        8th edition. Elsevier - OHCE, 2018 (Available from: Elsevier eBooks+)
        • Roberts D.
        • Brown J.
        • Medley N.
        • et al.
        Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2017; 3: CD004454
        • McGoldrick E.
        • Stewart F.
        • Parker R.
        • et al.
        Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2020; 12: CD004454
        • Liggins G.C.
        Premature delivery of foetal lambs infused with glucocorticoids.
        J Endocrinol. 1969; 45: 515-523
        • Bolt R.J.
        • van Weissenbruch M.M.
        • Lafeber H.N.
        • et al.
        Glucocorticoids and lung development in the fetus and preterm infant.
        Pediatr Pulmonol. 2001; 32: 76-91
        • Kemp M.W.
        • Newnham J.P.
        • Challis J.G.
        • et al.
        The clinical use of corticosteroids in pregnancy.
        Hum Reprod Update. 2015; 22: 240-259
        • Stock S.J.
        • Thomson A.J.
        • Papworth S.
        Antenatal corticosteroids to reduce neonatal morbidity and mortality.
        BJOG. 2022; 129: e35-e60
        • Reddy U.M.
        • Deshmukh U.
        • Dude A.
        • et al.
        Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: Replaces SMFM Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, 2016.
        Am J Obstet Gynecol. 2021; 225: B36-B42
        • Crowther C.A.
        • McKinlay C.J.
        • Middleton P.
        • et al.
        Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.
        Cochrane Database Syst Rev. 2015; 2015: CD003935
        • Gyamfi-Bannerman C.
        • Son M.
        Preterm premature rupture of membranes and the rate of neonatal sepsis after two courses of antenatal corticosteroids.
        Obstet Gynecol. 2014; 124: 999-1003
        • Murphy K.
        • for the MACS Collaborative Group
        Multiple courses of antenatal corticosteroids for preterm birth study.
        Am J Obstet Gynecol. 2007; 197: S2
        • Crowther C.A.
        • Harding J.E.
        Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.
        Cochrane Database Syst Rev. 2007; 3: CD003935
        • Gyamfi-Bannerman C.
        • Thom E.A.
        • Blackwell S.C.
        • et al.
        NICHD Maternal–Fetal Medicine Units Network. Antenatal betamethasone for women at risk for late preterm delivery.
        N Engl J Med. 2016; 374: 1311-1320
        • Saccone G.
        • Berghella V.
        Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials.
        BMJ. 2016; 355: e1
        • van der Merwe J.
        • van der Veeken L.
        • Inversetti A.
        • et al.
        Neurocognitive sequelae of antenatal corticosteroids in a late preterm rabbit model.
        Am J Obstet Gynecol. 2022; 226 (Epub 2021 Dec 4. PMID: 34875248): 850.e1-850.e21
        • Räikkönen K.
        • Gissler M.
        • Kajantie E.
        Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children.
        JAMA. 2020; 323: 1924-1933
        • Stutchfield P.R.
        • Whitaker R.
        • Gliddon A.E.
        • et al.
        Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial).
        Arch Dis Child Fetal Neonatal Ed. 2013; 98: F195-F200
        • Dalziel S.R.
        • Lim V.K.
        • Lambert A.
        • et al.
        Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial.
        BMJ. 2005; 331: 665
        • Liggins G.C.
        • Howie R.N.
        (1972). A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
        Pediatrics. 1972; 50: 515-525
        • American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics
        Practice bulletin no. 171: management of preterm labor.
        Obstet Gynecol. 2016; 128: e155-e164
        • Committee Opinion No
        455: Magnesium sulfate before anticipated preterm birth for neuroprotection.
        Obstet Gynecol. 2010; 115: 669-671
        • Anotayanonth S.
        • Subhedar N.V.
        • Garner P.
        • et al.
        Betamimetics for inhibiting preterm labour.
        Cochrane Database Syst Rev. 2004; 4: CD004352
        • King J.F.
        • Flenady V.J.
        • Papatsonis D.N.
        • et al.
        Calcium channel blockers for inhibiting preterm labour.
        Cochrane Database Syst Rev. 2002; 2: CD002255
        • Hawkins J.
        • Seth M.D.
        • Wells C.
        • et al.
        Nifedipine for acute tocolysis of preterm labor.
        Obstet Gynecol. 2021; 138: 73-78
        • King J.
        • Flenady V.
        • Cole S.
        • et al.
        Cyclo-oxygenase (COX) inhibitors for treating preterm labour.
        Cochrane Database Syst Rev. 2005; 2: CD001992
        • Lyell D.J.
        • Pullen K.
        • Campbell L.
        • et al.
        Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.
        Obstet Gynecol. 2007; 110: 61-67
        • Borna S.
        • Saeidi F.M.
        Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial.
        J Obstet Gynecol Res. 2007; 33: 631-634
        • Crowther C.A.
        • Hiller J.E.
        • Doyle L.W.
        Magnesium sulphate for preventing preterm birth in threatened preterm labour.
        Cochrane Database Syst Rev. 2002; 4: CD001060
        • FDA Drug Safety Communication
        New warnings against use of terbutaline to treat preterm labor. 2-2011.
        (Available at:) (Accessed June 15, 2022)
        • Nanda K.
        • Cook L.A.
        • Gallo M.F.
        • et al.
        Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth.
        Cochrane Database Syst Rev. 2002; 4: CD003933
        • Valenzuela G.J.
        • Sanchez-Ramos L.
        • Romero R.
        • et al.
        Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
        Am J Obstet Gynecol. 2000; 182: 1184-1190